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Mark and Jennifer Jones recently gave birth to
Sarah, a seemingly healthy newborn baby girl.
During the pregnancy, the Jones' physician
learns that both Mark and Jennifer have relatives
who have been diagnosed with cystic fibrosis.
Cystic fibrosis is a hereditary disease, and the
Jones's physician recommends that Sarah be
tested for the genetic abnormalities that lead
to the disease later in life. A small sample of
Sarah's blood is taken and sent to the hospital
laboratory. The hospital laboratory analyzes 87
of the most common genetic mutations that can
lead to Cystic Fibrosis. Unfortunately the tests
conclude that Sarah, although not currently
displaying any symptoms, will contract the
disease early in her life. After receiving these
results, Mark, Jennifer, the Jones' doctor, and
a genetic counselor discuss the results. The
doctor reviews all the medical options for a
young child who has cystic fibrosis, and stresses
how a well-balanced, high-calorie, high-protein
diet can help manage many of the symptoms.
T-he Jones' take the doctor's advice to heart,
and follow his advice in the care and early
upbringing of Sarah.i
T-he above scenario is an example of a genetic test
perfoimed through routine medical practice and is
presented, along with examples of other beneficial
genetic tests, on the United States Department of
Health and Humans Services' (HHS) Personalized
Health Care Initiative website." This is an example of
an ideal scenario where a genetic test can be performed
in the course of everyday medical practice, and in this
case, is a routine genetic test performed on all newborn
infants in many states.3 The benefits of performing a
test for cystic fibrosis are undoubtedly of enormous
and can lead to careful lifestyle planning and a much
improved and prolonged life for the individuals
affected.4
In contrast, what if the genetic testing described above
were performed with a larger or alternative focus in
mind? What if, instead of, or in addition to cystic
fibrosis, genetic testing reveals that Sarah will have
a sixty percent chance of developing a severe mental
illness such as schizophrenia by the time she is thirty?
What if genetic testing reveals if she will have a
seventy percent likelihood of developing Alzheimer's
by the time she is seventy? What if there is not a cure
or well-proven treatment to reduce the effects of these
debilitating conditions? Sarah could end up marked for
life.
Many of the fears associated with 'genetic marking'
have played out in science fiction works-primarily
based on the fear that genetic testing could predict
the potential intelligence, strength, or talents of a
particular individual and thus evolve into a new system
of discrimination and class distinction.N The real fear
still persists that Sarah, or individuals like her who
receive genetic testing. might be discriminated against
because of a genetic propensity to develop one or more
of a vast number of hereditary diseases in their life?
Perhaps an individual may exercise a right not to be
informed about non-curable genetic diseases or they
may deeline to know about any genetic abnormalities
whatsoever. But can an individual or the parent of
an individual decline all testing? If the testing is
performed, and the individual declines to be informed
of the results, what might happen if the information
is somehow disseminated to others, i.e., employers
or insurance companies or others who may exploit
such information for criminal purposes? What about
the possibilities that the genetic diseases are never
manifest?
As the practices and procedures of medicine are
evolving into a new ideology based on the treatment of
the individual pursuant to a 'personalized health care'
approach, there has never been a more important time
to ensure that the identities and private information
of those whose genes are being tested are thoroughly
respeeted and safIe-guarded.
T his article svill examine tlhe progress being made
towsard the developmxeint of personalized lhealth eare
medical systems based on the use of genetic testing,
the current and pending lasss required to protect the
genetic privacy of every human being, and the effects
of these systems on the American health care system
in general.
The Personalized Health Care Initiative
The Personalized H11ealth Care Initiative will
improve the safety, quality and effectiveness of
healthcare for every patient in the U. S. By using
genomics", or the identification of genes and
how they relate to drug treatment. personalized
health care will enable medicine to be tailored
to each person's needs. Healthcare that is
proactive, instead of reactive, gives the patient
the opportunity to become more involved in
their own wellness.
On March 23, 2007, former Secretary of Health and
Human Services, Mike Leavitt, identified a strategy
for achieving gene-based medical care combined with
the use of health information technology, something
he referred to as "Personalized Health Care" (the
Initiative).' Secretary 1eavitt commented that the
"initiative has the potential to transform the quality,
safety and value of health care for patients in the
future."' Ihe idea behind this initiative is to take
advantage of scientific breakthroughs resulting from
the human genome combined with recent technological
advancements to exchange and manage medical
information. This will result in an increased ability to
provide correct treatment to each individual patient at
just the right time. 10 Secretary Leavitt continued.
Gene-based medicine can help individuals
identify their particular susceptibilities to
disease while they are well and take effective
preventive steps. In the future, it will help detect
the onset of disease much earlier, enabling
treatment to prevent disease progression, and
can help bring about medical products that are
tailored more precisely to the needs of each
individual.. In the future, vse'll understand
diseases at a nesw lesvel.. AWe'll knoss them as
gene- or molecular-based diseases. And that
wsill gisve us ness kinds of treatments that wsill
be ettectisve foi both the svery specific condition
and the indiv idual patient.
U pon announcing this important initiatisve, Secretary
ILeasvitt turther identified the implementation steps that
the l'edeial Goveinment was already taking' lie also
emphasized that there is much ssoik remaining to build
a system capable of delivering effective personalized
health care.i1 In identifying the steps that HHS is
taking to lay the foundation for the Initiative, Secretary
Leavitt established that "HIlIS is engaged in a broad
review of the implications for privacy protection
as health information technology is increasingly
adopted., including needs for genetic information,.
and the anticipated effect on the confidentiality,
privacy and security of individually identifiable health
information."14
HHS seeks to advance the Initiative through
two guiding principles:
Provide federal leadership supporting research
addressing individual aspects of disease and
disease prevention with the ultimate goal of
shaping preventive and diagnostic care to match
each person's unique genetic characteristics.
Create a "network of networks" to aggregate
anonymous health care data to help researchers
establish patterns and identify genetic
"definitions" to existing diseases.i
With or without a federal initiative, it seems inevitable
that the practice of medicine is undoubtedly on course
to shift from a broad disease prevention and treatment
approach to a personalized approach where each
individual is treated based on his unique conditions and
needs-and, principally, genetics. The advantages the
Initiative offers include specific funding for the shift
in medical practice and the benefit of Congressional
oversight to assure that protective measures are put in
place for the protection of privacy.
IL. Privacy Concerns
Privacy concerns in genetic testing and health care
are not ness. As a result of modern advances in
genetic testing, individuals fear not only what they
might discover about themselves but what others,
like employers or health insurance providers, might
discover about them.i( Due to recent advancements in
technology many of these past fears are perhaps closer
than ever before.
The Personalizcd Medicine Coalition (PM4C), "an
independent, non-profit group that vsorks to adsvance
the undeirstanding and adoption of personalized
medicine for the ultimate benefit of patients,"" came
out in support of the Initiatisve. " Howvevecr. the PMC
quickly idcntificd many of the privacy concerns
that must be osvercome in order tor the Initiative to
come to fr'uition."' In identity ing, these obstacles, the
PMC pointed out that "[s]esveral sursvey s hasve been
conducted to gauge public opinion aiound the use
and protection of genetic information ... Itihe surveys
revealed that more than two-thirds of the public is
concerned about potential misuse of genetic information." 20 About one-
third of the public are of the opinion that if legal protections are not put
in place, concerns revolving around privacy could prevent individuals
from utilizing or participating in any genetic research.21 The concern is
that greater technological advances will be made without equal advances
in protective measures.
PMC expounds upon the data gathered in the surveys by identifying the
specific concerns of the general population:
PMC believes that all genetic information, including family history,
deserves strong and enforceable protections against misuse in
health insurance and employment, and PMC supports passage of
the Genetic Information Nondiscrimination Act. The benefits of
personalized medicine can only be fully realized when the fear of
genetic discrimination, and its actual practice, are eliminated trom
the healthcare system."L
The concerns presented by PMC and many other groups who cautiously
support the advancement of personalized medical care are just now being
addressed.
III. The Genetic Information Nondiscrimination Act
On May 21 2008, Congress passed, and former President George W. Bush
signed into lawx, the Genetic Information Nondiscrimination Act of 2008
(GINA), as a solution for many of the concerns associated with genetic
testing and personalized health care.23
GINA is modeled after Title VII of the 1964 Civil Rights Act./_ GINA
protects employees, job applicants and family members by prohibiting
employers and health insurers from requesting. requiring, or even buying
genetic information about them. Additionally, GINA strictly prohibits
health insurers from purchasing genetic information for underwriting
purposes."
a. Employment Discrnimination
The IEqual Employment Opportunity Commission (1EEOC) has been
charged with promulgating regulations to enforce GINA. In the realm
of employment discrimination, GINA brings in a whole new world of
enforcement for the Equal Employment Opportunity Commission.
Particular difficulty in enforcing GINA revolves around six loopholes
or exceptions to its prohibition on the use or collection of genetic
information. TIhese include: the inadvertent acquisiti of medical
intormation (the so called xwater cooler exception), health or genetic
serxvices, genetic monitoring of the biological ettects ot toxic substances.
Fedeiral or state Family and M edical Leaxve Acts, compliance. commerciallx
and publicly axvailable iecords, and laxx enforcement)2 These exceptions
leaxve significant leexxay for an employer to obtain information and use
that information to discriminate against an employeec. The position of the
EEOC, hoxxever, is that an employment decision based on genetic testing is
in xviolation of the laxx.x TIhe idea is that any test xxhich purports to predict
future disabilities, xxhether it is accurate or not, is unlikely to be relev ant to
the employece's present ability to perform his or her job.'
Another issue is that the EEOC has very little experience with regulating
genetic information.Xo One notable case took place in 2001, when the EEOC
filed its first lawsuit challenging genetic testing. Ihe case took place in the
IEastern District of Wisconsin and the parties' settled for $2.2 million.i
The allegation presented by the EEOC was that the company had "violated
the ADA by requiring dozens of employees to provide blood samples in
medical exams after they submitted claims for work-related carpal tunnel
syndrome."" The blood from the medical exams was secretly used in tests
to determine if an employee had any possible genetic predisposition for
carpal tunnel syndrome.33
With the passage of GINA, the number of employee genetic discrimination
cases may rise significantly. Though the number ofU.S. companies that are
conducting medical tests of employees is dropping, according to surveys
by the American Management Association, at least some companies were
conducting tests that might be in violation of GINA.34 The American
Management Association found that three percent of companies reported
medical testing for breast or colon cancer, two percent for sickle-cell
anemia, and one percent for IHIuntington's disease; all of which can have
genetic links.3 In addition, these surveys found that fifteen percent of
companies collected family medical histories which can reveal hereditary
genetic predispositions for specific diseases." 6Efmployers need to take
uigent measures to ensure that employees and all necessary parties are
sufficiently instructed on the nondiscriminatory measures within GINA and
adequately warned about the consequences of violating GINA.'
b. Insurance Dicrimination
GINA fills in the gaps of current federal law such that all health
insurers-whether governmental, private. group or individual-would
be forbidden to discriminate on the basis of genetic information.
lealth insurers may not use genetic information to determine
eligibility or set premiums. Ihey cannot use genetic information to
impose enrollment restrictions or adjust premium or contribution
amounts. IHealth insurers may not require or even request genetic
testing or test results, except as necessary for treatment, payment
or health care operations. This includes requesting, requiring or
purchasing genetic information prior to enrollment.)
Fhough GINA's health insurance protection provisions appear to be near
watertight, it will be important for lawmakers to keep an eye on insurance
companies to ensure they do not navigate around the provisions of GINA.
Careful attention will be required to assure GINA's exceptions are not
exploited at the expense of otherwise qualifying individuals.
The passage of GINA is a step in the right direction to protect private
information that may be collected in the course of practicing personalized
health care, but problems and questions persist. One concern associated xwith
the prixvacy of genetic information collected in the course of personalized
health care is that die information could still find its xxay into the hands of
an employ er or insuiance proxvider through one ot the loopholes.
While necessary prixacy protections must be. and are beinc put in place.
greater measures must be taken in order to oxvercoine the general public
mistrust of genetic testing. IThe measures must both resolve and dispel
public concerns and misconceptions revolving around genetic testing.
a The Right Aot to be Tested Right at to Know
What about an individual's right not to be tested or right to not know?
While much remains to be seen regarding this particular issue, legal
precedent says that "adults are free to refuse even potentially beneficial
testing and treatment... children [ however,] can be treated without their
[parent'sI consent (and over their parents' refusal) to prevent serious
imminent harm." 3 Currently. there is a great discord among the states as
to whether genetic testing is mandatory or can be refused.40 Some states
have no provision on refusing genetic testing, while others provide criminal
penalties for parents who refuse to have their children genetically tested.41
"The idea behind mandatory newborn screening is a benevolent one-to
trs to ensure that all children get the benefits of screening for PKU and
hypothyroidism, for which early treatment can make a dramatic difference
in the child's well-being by preventing mental retardation."4' However,
little evidence suggests that it is necessary for a newborn screening program
to be mandatory to ensure that children are screened.4 Rather, evidence
suggests that a voluntary program is more effective and reaches a higher
percentage of children.44
Though it may be difficult to comprehend where such a requirement would
be initiated, making adults undergo genetic testing for any reason would
appear to be even less effective and may only crcate more distrust in the
system. Further, for adults who are tested, many may wish to exercise a
right not to know the results of their tests.
I[Giving a patient a right to refuse genetic testing, or its results,.
is justified as vindicating a patient's autonomy, a 'basic bioethical
principle.'... [T]hough such choices are often justified by a rational
interest in remaining free of the psychological harm that might
follow from receiving test results, the right to assess that harm and
make a choice whether to know lies solely with the patient.45
Another consideration is whether the individual being tested, or the parent
of the child who is tested. is capable of living with the knowledge that
he, or his child, is plagued with a genetic identity that will likely lead to
disease. Parents who are carriers of genetic diseases may feel desperate
and guilty for passing on a disease to their children 46 "Studies have shown
that knowing that one is at risk for genetic conditions or even learning that
one does not have [a defective gene] strongly affects self-perception and
life experiences."4 1any individuals, for example, suffer from depression
when they learn that they have a gene responsible for causing 1luntington
disease (ID)-some have gone so far as to commit suicide.48 "Not
surprisingly, many who were at risk [for HD]I and discover they do not
carry the mutation feel liberated. But, after hnsving lixved xxith a sense of
being at risk, some hasve difficulty adjusting to the knoswledge that thes xwill
not deselop HD."49
Ait the svery least, iegulations should be considered to alloss individuals.
including childien (through paients), to exercise the iight not to be tested
for genetic disorders for wxhich there is no cure or cffective ctreatment.
b. The Use of Genetic Ifaormiation in Criminal lProceedings
Somc concerns loom as to wxhat might be done wxith the genetic information
collectcd. Wfhat if genetic propensities we re introduced ns cevidencc in
criminal trials? This type of concern is found in the area of neuroscience
and is associated with analyzing images of the brain with an MRI.
What if you could do a brain scan and determine to a high probability
whether a criminal defendant was a psychopath, with, for example,
a 60-70 percent chance of recidivism within five years instead of
only 20-30 percent? Would that make a difference to a judge or a
jury? What if you were a juror in a capital case in the sentencing
phase? Wfould you want to know if someone is a psychopath or not
if it affects his odds of committing another murder? How would we
want to use that information? ... What if you can say that...particular
12-year-olds will be psychopaths while the others won't be? What
do you do with the children you are confident will be psychopaths?50
This type of ethical dilemma is further implicated by advancements
in genetic testing. What if you could determine that an individual will
likely have a propensity (aside from simply having XY sex chromosomes
as opposed to XX sex chromosomes) to commit some form of violent
crime based on the presence of certain DNA structures? Certainly it
provides a basis for taking preventive measures by implementing lifestyle
adjustments-much like the result of discovering the likely risk for certain
diseases like cystic fibrosis. Should this information ever be presented in
a court of law, or disseminated to police officers? These are questions that
must be answered by the judiciar, or perhaps more preferably by Congress,
before these problems come to light.
c. A Revival ofEu genics?/
In the 1927 case Buck v Bell, the United States Supreme Court upheld a
Virginia statute that allowed for the forced sterilization of 'feeble minded'
and epileptic individuals that were committed to state institutions.
Specifically, the hearing procedure conducted before sterilization could be
performed was found to satisfy the Fourteenth Amendment because it did
not deny equal protection to inmates in state institutionS. 52 In his majority
opinion, Justice Hlolines wrote:
It is better for all the world, if instead of waiting to execute degenerate
offspring for crime, or to let them starve for their imbecility, society
can prevent those who are manifestly unfit from continuing their
kind. The principle that sustains compulsory vaccination is broad
enough to cover cutting the Fallopian tubes. T hree generations of
imbeciles are enough.53
What if genetic testing were used today for the same or similar purpose?
Though genetic testing is unlikely to lead to forced sterilization of those who
are 'genetically unfit,' a more realistic possibility is de-facto sterilization
where health care is denied to those considered unfit to reproduce. Although
this example is extrenme, and 55ould be unlikely to arise under GINA, it
illustrates the possibility that the results of genetic testing might need to
be protected fronm health care prosviders wxho hasve no apparent need for the
information.
In additional to prisvacy concerns, Use implenmentation of an effectisve
personalized health care plan wvill require other inmportant measures. Many
ot these measuies wxere laid out by the Personalized Medicine Coalition.
TFhese include educating physicians and other health care professionals
who will be responsible for treating patients and implementing su fficient
technology infornation systems to aid in the sharing of information.
PMC believes that extensive education will be required for
practicing physicians, medical school students, and a range of
healthcare professionals, to enable them to apply an ever-expanding
set of molecular approaches for individualized care for their
patients. Towards that end, PMC is collaborating with its member
organizations that have expertise in genetics and education to
develop a unique set of curricula.
Educating responsible parties appears to be one the biggest tasks at hand.
Chief amongst the education requirements should be an assurance that
health care personnel can effectively communicate the rights of patients
receiving genetic testing. This direct communication will further aid in the
protection of privacy.
Another area of concern is establishing sufficient health care information
technology (1H1T) systems such that information canbe easily communicated
between the appropriate parties.
PMC actively supports the creation of a national health information
network that enables the interoperable exchange of digital biomedical
infornmation securely between a diverse set of stakeholders in the
healthcare ecosystem. This infrastructure should also take into
account the unique needs of the basic., clinical and translational
research community. PMC supports the examination of potential
incentive structures to induce investment in HIT by all healthcare
providers, from solo practitioners to large hospitals.
The implementation of adequate 111 systems raises various concerns.
I ffective measures. including legislation, must be put in place to ensure the
protection of information that is stored or transferred over such systems.
A final concern and stated goal of the HHI IS Initiative is ensuring the
accuracy and validity of genetic tests.> Specific verification and testing
measures require implementation. Further, penalties for laboratories that
continually produce wrong results require contemplation.
Among the remaining steps of implementing the Initiative, great care and
concern still needs to be made for privacy. As new measures are taken and
new technological feats are reached, careful analysis of privacy protection
needs to be made at each milestone. Still, it is appropriate to consider a
far reaching privacy measure at this early stage. Nanely, Congress should
consider creating penalties for any party who sells the genetic information
of another or who seeks the genetic information of another to make a profit
or with malicious intent.
President Barack Obama declared his conmmitment to ensuring that
compiehensive health caie reform is passed wsithin this sear with the
stated goal of controlling rising healhh care costs. Giv en the President's
determination, caietulls assuring that a personalized health care initiatisve
is implemented could significantly contributc to the realization of this goal.
a.( Cost .Savings IUder the Initiative
The Initiative will ensure that the practice of medicine evolves into a practice
focused on the individual. As more accurate information about a patient is
produced., through genetic testing, the costs of treating certain illnesses and
conditions may be greatly reduced. Ihe turther use of typical hit and miss
treatment strategies could be completely abolished and replaced with more
narrow and individualized treatment plans. Ihis necessarily leads to a much
more effective and cost efficient system. No more time or money need be
wasted in 'attempting' to treat individuals.
b. Whi GNJ\A Further \ecessitates Coverage for All
GINAnow makes it illegal for health insurance companies to raise insurance
premiums for, or otherwise discriminate against, the class of individuals
found to have a genetic propensity for certain illnesses or for the class
of individuals who have a family history for certain illnesses." Insurers
might choose to quadruple the premiunis of or refuse to sell a policy to
the third class of individuals-those who are diagnosed with illnesses
through routine medical care." Moreover, it a member of this third class
"is enrolled in an employer-sponsored group health plan, insurers could
raise the rates for everyone in the group."6o
Researchers have argued that:
In making such distinctions, GINA is emblematic of this country's
piecemeal and inconsistent approach to health care policy, which
makes little sense and leaves many Americans without access to care
or in danger of financial ruin if they seek care. Our recent history is
replete with examples of similar half-measures in health policy. 'The
Emergency Medical Treatment and Active Labor Act (EMTALA)
of 1986 ensures that neither the poor nor the sick can be denied
emergency medical treatment, but it lenves those without insurance
completely on their own when it comes to follosw-up care. So when a
patient presents at the emergency room with a myocardial infarction
with ST-segment elevation, she will receive a lifesaving coronary-
arters stent. but she may not be able to afford Plavix (clopidogrel)
- which she must take to avert in-stent restenosis -and may not
have access to follow-up care, which might enable her to modify her
risk factors for heart disease. Medicare might help if the patient is 1
day past her 65th birthday, but not if she is I day shy of it. Medicaid
might help if her income is lower than the qualify ing threshold in her
state, but not if she earns $1 more>.6
Rather than leave out individuals who may have a genetic predisposition
for a disease but only find out through routine medical care, the
researchers argue that the better solution is outright prohibition of medical
underwriting-a prohibition on setting health insurance premiums based
upon any health care information.62
Moreosver, to cnsurc that the costs of bad health are shared equitably
all Americans w5ould hasve to be in the same risk pool. This sxould
mean enactino a hcaltb insurancc mandate citbcr for employ ers or,
if health insurancc could he nmadc affordablc. for indiv iduals -and
specify ing a minimum sct of benefits that esvery one 55ould be required
to hasve. Gixven the grossing disparity betswecn thc cost of modcrn
medicine and the inoes of many Americans, enforcing such a
mandate would be difficult. Eve w i ith incuoe-based subsidies, an
indisvidual msandate could place an undue financial burden on many
families. Nonetheless, bringing everyone into the same risk pool is
an important long-tenr goal.63
T-he goals of comprehensive health care reform, as stated by President
Obama, may go a long way in ensuring that health care costs for any
individual do not escalate out of control.
VIL. Conclusion
The practice of medicine is on the verge of noving into a new frontier of
personalized health care. "The H111S Initiative indeed promises to enthrone
a revolutionary approach to the practice of medicine where the focus is on
the individual needs of each patient as determined by genetic screening.
As the practice of medicine shifts into this new frontier, it is important that
the government ensure the protection of each individual's genetic privacy.
GINA provides a substantial step towards protecting an individual's private
genetic information against the possibilities of being used for employment
or health care insurance discrimination. The beginning steps have been
taken, but much needs to be done to ensure that each individual maintains
his or her rights regarding genetic testing and the right to not be tested
or the right to not know test results. Further, it is of vital importance that
Congress keeps a close eye on the progress being made within this field and
on the efforts of those who would seek to thwart the laws.
As medicine moves into this new realm of personalized health care, it
would be a huge advantage for all parties involved, especially the federal
government, to take advantage of the opportunities that personalized
health care offers. Specifically, as health care reform is considered and
established, the cost benefits of carefully implementing personalized health
care initiatives cannot be ignored.
The words of Professor lenry T. Greeley of Stanford U niversity L ass
School apply: "although this stuff is really interesting, we need make sure
it works before we use it. Let's make sure we understand what it can and
can't do. And, as a society, we don't do patience very well."64 Let us be
patient and careful in protecting the rights of all mankind.
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